Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients.

Szük, Tibor

Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients. [electronic resource] - Platelets 07 2016 - 410-9 p. digital

Publication Type: Clinical Trial; Journal Article

1369-1635

10.3109/09537104.2015.1112368 doi


Aged
Angina, Stable--complications
Biomarkers
Blood Platelets--metabolism
CD40 Ligand--blood
Comorbidity
Coronary Restenosis--blood
Drug-Eluting Stents
Endothelial Cells--metabolism
Everolimus--administration & dosage
Female
Humans
Intercellular Adhesion Molecule-1--blood
Male
Middle Aged
Phosphorylation
Platelet Activation
Platelet Aggregation Inhibitors--pharmacology
Risk Factors
Severity of Illness Index
Stents--adverse effects